Today: 19 May 2026
Browse Category

LSE:GSK.L 28 November 2025 - 2 March 2026

Why GSK stock is moving today: Exdensur EU nod and a fresh buyback

Why GSK stock is moving today: Exdensur EU nod and a fresh buyback

GSK shares rose 1.1% to 2,263 pence after the European Commission approved its twice-yearly asthma drug Exdensur and the company launched a new tranche of share buybacks. GSK will repurchase up to £0.45 billion in shares by April 24. The company also reported new real-world data showing its RSV vaccine Arexvy was 75.6% effective against RSV-related hospitalisation in adults over 60.
18 February 2026
··
GSK stock price in focus before London open after China starts Arexvy review

GSK stock price in focus before London open after China starts Arexvy review

China’s Center for Drug Evaluation has accepted GSK’s Arexvy RSV vaccine application for review, with a decision expected in 2027. GSK shares closed Tuesday up 0.42% at 2,168 pence ahead of the London open. JPMorgan raised its target price to £22.50, and the company’s next dividend goes ex-dividend on Feb. 19. Non-executive director Hal Barron sold 67,602 ADSs at $59.17 on Feb. 5.
11 February 2026
·
GSK stock slips in London as hepatitis B drug details awaited; Feb 4 results loom

GSK stock slips in London as hepatitis B drug details awaited; Feb 4 results loom

GSK shares slipped 0.6% to 1,879.5p in London by 10:50 GMT as investors awaited detailed data from its phase III hepatitis B drug trial. Analysts pressed for cure rate and durability figures after GSK withheld specifics. A royalty dispute over cancer drug Jemperli is pending in U.S. court, with a trial set for July 2026. Investors are watching for updates at the Jan. 13 J.P. Morgan conference and Feb. 4 results.
9 January 2026
···
Most Active UK Stocks Today (9 December 2025): BP, Barclays, Rolls‑Royce, Unilever and More in Focus

Most Active UK Stocks Today (9 December 2025): BP, Barclays, Rolls‑Royce, Unilever and More in Focus

The FTSE 100 closed down 0.2% at 9,645.09 on Monday, with heavy trading concentrated in BP, Barclays, Rolls-Royce, Unilever, Lloyds, HSBC, London Stock Exchange Group, Anglo American, GSK, and British American Tobacco. Investors pulled back ahead of key US Federal Reserve and Bank of England rate decisions. FTSE 100 futures hovered near 9,657 early Tuesday, with technical signals pointing to caution.
9 December 2025
···········
Best UK Stocks to Buy Today (8 December 2025): 7 FTSE 100 Ideas for a Potential Rate‑Cut Era

Best UK Stocks to Buy Today (8 December 2025): 7 FTSE 100 Ideas for a Potential Rate‑Cut Era

The FTSE 100 closed near 9,660 on December 8, posting a total return of about 20–23% year-to-date, its best run since 2009. The Bank of England has held rates at 4% since August, with inflation at 3.6%. Markets expect a rate cut to 3.75% at the December 18 meeting. UK mortgage rates have dropped to their lowest since before September 2022.
8 December 2025
·········
GSK plc Stock Today, 28 November 2025: Buybacks, ‘Hold’ Ratings and Pipeline Momentum Keep Shares Near Highs

GSK plc Stock Today, 28 November 2025: Buybacks, ‘Hold’ Ratings and Pipeline Momentum Keep Shares Near Highs

GSK shares traded near 12-month highs on November 28, 2025, with London shares at 1,806p, up 0.2%, and New York ADRs at $48.02, just below their yearly peak. MarketBeat issued a fresh “Hold” consensus from seven analysts, with an average 12-month price target of $44.13, under current levels. The stock’s recent gains follow continued share buybacks and a busy drug pipeline.
28 November 2025
··

Stock Market Today

  • U.S. Stock Futures Slide on Tech Selloff, War Concerns - May 19, 2026
    May 19, 2026, 8:53 AM EDT. U.S. stock futures declined Tuesday amid another drop in technology shares, dragging the S&P 500 and Nasdaq lower for the second day. Investor sentiment weakened on escalating geopolitical tensions, introducing war uncertainty that added pressure to risk assets. The tech selloff weighed heavily, reflecting ongoing concerns over sector valuations and potential earnings risks. Markets remained cautious as traders balanced these factors against broader economic indicators.

Latest articles

Wellgistics Health Doubles, WGRX Heads Into Key Test

Wellgistics Health Doubles, WGRX Heads Into Key Test

19 May 2026
Wellgistics Health shares fell 21.1% to $0.14 in premarket trading Tuesday after more than doubling Monday. The company delayed its quarterly report, withdrew proxy materials, and is reviewing potential strategic transactions. First-quarter results are due after the market closes. The moves follow a non-binding $15 million acquisition proposal for WellCare Today.
Roblox Stock Moves Up Early, Safety Issues Still Linger

Roblox Stock Moves Up Early, Safety Issues Still Linger

19 May 2026
Roblox shares traded at $47.41 in early New York hours Tuesday, extending gains after third-party data showed a week-over-week rise in concurrent users. Needham maintained its Buy rating and $60 target. The stock remains pressured by a lowered 2026 bookings outlook, tied to new safety and age-check measures. Roblox reported Q1 revenue of $1.4 billion and bookings of $1.7 billion.
Amer Sports Rises Premarket on Salomon Strength

Amer Sports Rises Premarket on Salomon Strength

19 May 2026
Amer Sports raised its 2026 sales, margin, and profit outlook after first-quarter revenue jumped 32% to $1.95 billion, beating forecasts. Shares rose 4.18% in premarket trading to $34.54. Adjusted earnings reached 38 cents a share, above analysts’ estimates. Growth was led by Arc’teryx, Salomon softgoods, and Wilson Tennis 360.

Popular

Roblox Shares Jump Almost 10%, Safety Issue Remains Unanswered

Roblox Shares Jump Almost 10%, Safety Issue Remains Unanswered

18 May 2026
Roblox shares rose 9.6% to $46.98 on Monday, bucking declines in the broader tech sector. The jump followed a month-long selloff tied to new child-safety measures, which the company says have reduced user communication and slowed new sign-ups. Roblox cut its 2026 bookings outlook on April 30, but first-quarter revenue and daily active users both rose over 35%. Analysts cited competition from Fortnite and the upcoming Grand Theft Auto VI.
Go toTop